GSK Retained Earnings (Accumulated Deficit) 2010-2024 | GSK
- GSK retained earnings (accumulated deficit) for 2023 were $9.005B, a 66.86% increase from 2022.
- GSK retained earnings (accumulated deficit) for 2022 were $5.397B, a 50.6% decline from 2021.
- GSK retained earnings (accumulated deficit) for 2021 were $10.924B, a 25.95% increase from 2020.